Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
PureTech Health PLC 01 November 2024 PureTech Health plc Total Voting Rights and Share Capital - Month End Disclosure Pursuant to DTR 5.6.1 of the Disclosure Guidance and Transparency...
PureTech Health PLC 31 October 2024 31 October 2024 PureTech Health plc PDMR Notification PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage...
PureTech Health PLC 21 October 2024 21 October 2024 PureTech Health plc PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round Financing...
PureTech Health PLC on Wednesday said a new patient survey for people with idiopathic pulmonary fibrosis has provided ...
PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophren ...
PureTech Health PLC 27 September 2024 27 September 2024 PureTech Health plc PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia...
PureTech Health PLC 06 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BY2Z0H74 Issuer Name PURETECH HEALTH PLC UK or Non-UK Issuer UK 2...
LC - Boston, Massachusetts-based biotechnology company - Founded entity Vor Bio, a clinical stage cell and genome engi ...
ech Health PLC half-year revenue and pretax loss.) (Alliance News) - PureTech Health PLC on Wednesday reported a wide ...
PureTech Health PLC on Wednesday reported a widened loss and lower revenue, as it attempted to address shareholder co ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.6 | 2.22222222222 | 162 | 173.2 | 157.2 | 496865 | 165.91027256 | DE |
| 4 | 5.6 | 3.5 | 160 | 175.4 | 152.2 | 712900 | 163.39491219 | DE |
| 12 | 9 | 5.74712643678 | 156.6 | 175.4 | 139 | 711907 | 153.46039253 | DE |
| 26 | -62.4 | -27.3684210526 | 228 | 238.5 | 139 | 556758 | 166.78332012 | DE |
| 52 | 2.2 | 1.34638922889 | 163.4 | 238.5 | 139 | 517920 | 179.6023338 | DE |
| 156 | -157.9 | -48.8098918083 | 323.5 | 323.5 | 139 | 380672 | 203.49409603 | DE |
| 260 | -123.4 | -42.6989619377 | 289 | 446 | 139 | 316994 | 235.50103285 | DE |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
